Is it time for a new approach to the initial treatment of hypertension?

Archives of Internal Medicine

Volumn 161, Issue 9, 2001, Pages 1140-1144

  Moser, M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; COMORBIDITY; HEART FAILURE; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034918269     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.9.1140     Document Type: Note

References (23)

1. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish trial in old patients with hypertension-2 study
2. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness
3. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
5. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
6. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
7. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
8. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
9. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
10. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
11. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease
12. An overview of the meta-analyses of the hypertension treatment trials
13. Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly
14. Treating hypertension: Calcium channel blockers, diuretics, β-blockers, ACE inhibitors: Is there a difference?
15. Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: A review of potential benefits and possible adverse reactions
16. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)
17. Medical Research Council trial of treatment of hypertension in older adults principal results
18. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and the MICRO HOPE substudy
19. Meta-analysis of calcium channel blockers in hypertension
20. Calcium antagonists: Not appropriate as first-line antihypertensive agents
21. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension